The research of VCE-003.2 on Huntington´s Disease has been published in Scientific Reports


Córdoba, July 19th of 2016. The high potential of VCE-003.2 for the treatment of Huntington´s Disease (HD) and other neurodegenerative diseases with neuroinflammatory traits has been described in the paper published in the last number of the Scientific Reports journal. The work has been coordinated by researches of Maimonides Biomedical Research Institute at Córdoba (IMIBIC, Spain) and VivaCell, in collaboration with the Institute Ramón y Cajal of Health Research (IRYCIS, Madrid, Spain), the University Complutense of Madrid (Spain), the Network of Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain), and the University of the Piamonte Orientale (Italy).

Más información:

Developed with DoPlanning